In preparing the report on which this presentation is based, the authors aimed to answer two Key Questions (KQs). KQ 1 is listed below:
KQ 1. In patients receiving intensive insulin therapy, does mode of delivery (CSII vs. MDI) have a differential effect on process measures, intermediate outcomes, and clinical outcomes in patients with diabetes mellitus?
Do these effects differ by:
a. Type 1 or type 2 diabetes status?
b. Age: very young children, adolescents, and adults, including older adults (>65 years)?
c. Pregnancy status: pre-existing type 1 or type 2 diabetes?
Abbreviations: CSII = continuous subcutaneous insulin infusion; MDI = multiple daily injections